Literature DB >> 18266863

Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates.

Alexander Just1, Sabine Adams, Thomas Brinkmeier, Vahé Barsegian, Johannes Lorenzen, Fritz Schilling, Peter Frosch.   

Abstract

The treatment of the painful osteomyelitis in patients with SAPHO syndrome (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis) is often a problem. A 53-year-old woman had experienced palmo-plantar pustular skin lesions for four years, and in the past two years complained about progressive breath-and movement-dependent pain of the sternum. On examination she had extensive palmoplantar pustules and a painful swelling in the area of the right sternoclavicular joint. The three-phase bone scintigraphy showed a strong focal enrichment in the right sternoclavicular joint and at the transition from the manubrium to the corpus sterni suggesting active osteo-chondritis. Initially prednisolone and ibuprofen were administered, but only the skin changes regressed. The strong sternal pain decreased only after infusion of 4 mg zoledronic acid over three days. In a follow-up examination after five months the patient was still free of pain. The bisphosphonates inhibit osteoclastic activity and lead to long-lasting improvement of osteo-articular complaints in the SAPHO syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266863     DOI: 10.1111/j.1610-0387.2008.06588.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  7 in total

Review 1.  New discoveries in CRMO: IL-1β, the neutrophil, and the microbiome implicated in disease pathogenesis in Pstpip2-deficient mice.

Authors:  Polly J Ferguson; Ronald M Laxer
Journal:  Semin Immunopathol       Date:  2015-04-17       Impact factor: 9.623

Review 2.  The SAPHO syndrome revisited with an emphasis on spinal manifestations.

Authors:  Antonio Leone; Victor N Cassar-Pullicino; Roberto Casale; Nicola Magarelli; Alessia Semprini; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2014-10-21       Impact factor: 2.199

3.  SAPHO syndrome with bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer.

Authors:  Katsuhiko Matsumaru; Kazuki Nagai; Takayuki Murakami; Kazuo Andoh
Journal:  BMJ Case Rep       Date:  2010-08-31

Review 4.  New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.

Authors:  Marina Magrey; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

Review 5.  The effectiveness of treatments for patients with SAPHO syndrome: a follow-up study of 24 cases from a single center and review of literature.

Authors:  Hong Huang; Zhuoli Zhang; Juan Zhao; Yanjie Hao; Wei Zhou
Journal:  Clin Rheumatol       Date:  2020-08-13       Impact factor: 2.980

Review 6.  New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.

Authors:  Wei Cheng; Fen Li; Jing Tian; Xi Xie; Jin-Wei Chen; Xiao-Fei Peng; Qi Tang; Yan Ge
Journal:  J Inflamm Res       Date:  2022-04-13

7.  Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study.

Authors:  Gunter Assmann; Olaf Kueck; Timm Kirchhoff; Herbert Rosenthal; Jan Voswinkel; Michael Pfreundschuh; Henning Zeidler; Annette D Wagner
Journal:  Arthritis Res Ther       Date:  2009-10-09       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.